No Harm Act

Bill 119 HR 2387, also known as the "Protecting Children from Experimentation Act," aims to prevent the use of federal funds for sex-trait altering treatments for minors. This bill specifically targets treatments such as hormone therapy and gender reassignment surgery for individuals under the age of 18.

The bill states that these treatments can have long-term physical and psychological consequences for minors, and therefore should not be funded by the federal government. Supporters of the bill argue that minors are not capable of fully understanding the implications of such treatments and should not be subjected to them without proper consent and guidance.

Opponents of the bill argue that it infringes on the rights of individuals to make decisions about their own bodies and medical care. They also argue that denying access to these treatments can have negative effects on the mental health and well-being of transgender youth. Overall, Bill 119 HR 2387 is a controversial piece of legislation that raises important questions about the rights of minors, the role of the federal government in healthcare, and the ethical considerations surrounding sex-trait altering treatments for minors.